相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2021)
Collateral sensitivity associated with antibiotic resistance plasmids
Cristina Herencias et al.
ELIFE (2021)
Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase
Christopher I. Ma et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Entamoeba histolytica-Gut Microbiota Interaction: More Than Meets the Eye
Serge Ankri
MICROORGANISMS (2021)
Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies
Nader S. Abutaleb et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Formation of oxidised (OX) proteins in Entamoeba histolytica exposed to auranofin and consequences on the parasite virulence
Yana Shaulov et al.
CELLULAR MICROBIOLOGY (2020)
An Alcohol Dehydrogenase 3 (ADH3) from Entamoeba histolytica Is Involved in the Detoxification of Toxic Aldehydes
Constantin Koenig et al.
MICROORGANISMS (2020)
Role of kinases in virulence and pathogenesis of protozoan parasite E. Histolytica
Azhar Ahmad et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2020)
Antibacterial and antivirulence activities of auranofin against Clostridium difficile
Ahmed AbdelKhalek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Potential Anticancer Activity of Auranofin
Takefumi Onodera et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders
Seyed Jalal Hashemi et al.
INFECTION AND DRUG RESISTANCE (2019)
Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus
Mike Marvin Ruth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Characterization of Entamoeba histolytica adenosine 5′-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis
Fumika Mi-ichi et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
An Overview of Drug Resistance in Protozoal Diseases
Rita Capela et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
Ahmed AbdelKhalek et al.
SCIENTIFIC REPORTS (2018)
High-Throughput Screening of Entamoeba Identifies Compounds Which Target Both Life Cycle Stages and Which Are Effective Against Metronidazole Resistant Parasites
Gretchen M. Ehrenkaufer et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Identification of S-Nitrosylated (SNO) Proteins in Entamoeba histolytica Adapted to Nitrosative Stress: Insights into the Role of SNO Actin and In vitro Virulence
Meirav Trebicz-Geffen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Entamoeba histolytica under Oxidative Stress: What Countermeasure Mechanisms Are in Place?
Erika Pineda et al.
CELLS (2017)
Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo
Melissa Hopper et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action
Derek Parsonage et al.
JOURNAL OF STRUCTURAL BIOLOGY (2016)
Proteomic Identification of Oxidized Proteins in Entamoeba histolytica by Resin-Assisted Capture: Insights into the Role of Arginase in Resistance to Oxidative Stress
Preeti Shahi et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target
David Leitsch et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2016)
Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
Shankar Thangamani et al.
SCIENTIFIC REPORTS (2016)
The intestinal protozoa: emerging impact on global health and development
Joshua A. Turkeltaub et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Presence of antioxidative agent, Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro- in newly isolated Streptomyces mangrovisoli sp nov.
Hooi-Leng Ser et al.
FRONTIERS IN MICROBIOLOGY (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
Noa Tejman-Yarden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Identification of dihydropyrimidine dehydrogenase as a virulence factor essential for the survival of Entamoeba histolytica in glucose-poor environments
Sharon Baumel-Alterzon et al.
CELLULAR MICROBIOLOGY (2013)
Redox regulation of protein kinases
Aoife Corcoran et al.
FEBS JOURNAL (2013)
G protein signaling in the parasite Entamoeba histolytica
Dustin E. Bosch et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Entamoeba histolytica thioredoxin reductase: Molecular and functional characterization, of its atypical properties
Diego G. Arias et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Anjan Debnath et al.
NATURE MEDICINE (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Cysteine-Based Redox Switches in Enzymes
Chananat Klomsiri et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Localization and Targeting of an Unusual Pyridine Nucleotide Transhydrogenase in Entamoeba histolytica
Mohammad Abu Yousuf et al.
EUKARYOTIC CELL (2010)
Pyruvate:ferredoxin oxidoreductase and bifunctional aldehyde-alcohol dehydrogenase are essential for energy metabolism under oxidative stress in Entamoeba histolytica
Erika Pineda et al.
FEBS JOURNAL (2010)
Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin STRUCTURAL AND KINETIC ASPECTS
Francesco Angelucci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au-Se adduct
Sarah Jackson-Rosario et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells
Warren Fiskus et al.
BLOOD (2008)
Isolates of Clostridium perfringens recovered from Costa Rican patients with antibiotic-associated diarrhoea are mostly enterotoxin-negative and susceptible to first-choice antimicrobials
Natassia Camacho et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Nitroimidazole action in Entamoeba histolytica:: A central role for thioredoxin reductase
David Leitsch et al.
PLOS BIOLOGY (2007)
Thioredoxin glutathione reductase from schistosoma mansoni:: An essential parasite enzyme and a key drug target
Angela N. Kuntz et al.
PLOS MEDICINE (2007)
Eh Klp5 is a divergent member of the kinesin 5 family that regulates genome content and microtubular assembly in Entamoeba histolytica
Promita Ghosh Dastidar et al.
CELLULAR MICROBIOLOGY (2007)
Sensing DNA methylation in the protozoan parasite Entamoeba histolytica
Tal Lavi et al.
MOLECULAR MICROBIOLOGY (2006)
Drug susceptibility testing of anaerobic protozoa
JA Upcroft et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
The Ras GDP/GTP cycle is regulated by oxidizing agents at the level of Ras regulators and effectors
K Accorsi et al.
FEBS LETTERS (2001)
Superoxide dismutase reduces susceptibility to metronidazole of the pathogenic protozoan Entamoeba histolytica under microaerophilic but not under anaerobic conditions
C Wassmann et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
分享论文
